Chris Semsarian, PhD, MPH, has been announced as the newest editor-in-chief of the American Heart Association’s journal Circulation: Genomic and Precision Medicine.
Semsarian, a professor at the University of Sydney, director of the Genetic Heart Disease and Hypertrophic Cardiomyopathy Clinic at Royal Prince Alfred Hospital and director of the Australian Genetic Heart Disease Registry, served as senior guest editor for the journal prior to becoming its editor-in-chief. His roster of work includes more than 250 scientific publications and best practice guidelines for inherited heart diseases.
Circulation: Genomic and Precision Medicine first launched in 2008 with the goal of investigating the clinical genetics and novel applications of precision medicine. Semsarian said he plans to incorporate some new features into the journal’s regular rotation, including “state-of-the-art” contemporary reviews, more guideline documents and clinical case reports, and visual abstracts. He also said he wants to boost the journal’s social media presence with Twitter-based “tweetorials” and journal clubs.
“My vision is for the journal to be the ‘go-to’ journal for the latest, state-of-the-art research studies in the field of cardiovascular genomics and precision medicine, with an expanding readership to encompass more general cardiologists, geneticists and other allied health professionals,” Semsarian said in a statement July 29. “I also want to ensure the journal is inclusive, with goals to ensure equal representation of women as associate and assistant editors and on the editorial board.”
Semsarian will be taking the reins from Erik Ingelsson, the interim editor-in-chief for the journal.
After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.